Want to see TSE:GPIN full AI Analyst Report?
Steep Hill Inc (GPIN) Price & Analysis
GPIN Stock Chart & Stats
- Day’s Range
- CAD 0.18 - CAD 0.18
- 52-Week Range
- CAD 0.18 - CAD 0.75
- Previous Close
- CAD 0.19
- Volume
- N/A
- Average Volume (3M)
- 6,180
- Market Cap
- CAD 7.30M
- Enterprise Value
- CAD 11.93M
- Total Cash (Recent Filing)
- CAD 2.03M
- Total Debt (Recent Filing)
- CAD 0
- Price to Earnings (P/E)
- 0.4
- Beta
- 0.56
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Industry Partnerships
Partnerships with industry players and regulatory bodies enhance Steep Hill's credibility and revenue potential, supporting long-term business sustainability and compliance.
Strong Balance Sheet
A strong balance sheet with no debt provides financial stability and flexibility, allowing Steep Hill to invest in growth opportunities without the burden of leverage.
Strategic Acquisition
The acquisition of Lir Life Sciences positions Steep Hill in the biopharmaceutical sector, potentially expanding its market reach and product offerings, which could enhance long-term growth prospects.
Bears Say
Operational Inefficiencies
Persistent operational inefficiencies, as indicated by negative margins, suggest challenges in cost management and profitability, affecting long-term business viability.
Negative Cash Flow
Negative cash flow indicates operational inefficiencies and potential liquidity challenges, which could hinder Steep Hill's ability to sustain operations without external financing.
Lack Of Revenue
The absence of revenue poses a significant risk to Steep Hill's long-term sustainability, as it limits the company's ability to fund operations and growth initiatives.
Steep Hill Inc News
GPIN FAQ
What was Steep Hill Inc’s price range in the past 12 months?
What is Steep Hill Inc’s market cap?
When is Steep Hill Inc’s upcoming earnings report date?
How were Steep Hill Inc’s earnings last quarter?
Is Steep Hill Inc overvalued?
Does Steep Hill Inc pay dividends?
What is Steep Hill Inc’s EPS estimate?
How many shares outstanding does Steep Hill Inc have?
What happened to Steep Hill Inc’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Steep Hill Inc?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Steep Hill Inc
Steep Hill Inc., a cannabis science and technology company, provides laboratory testing, quality assurance, and data analytics services in Canada and the United States. It offers analytical testing services, such as cannabinoids, terpenes, pesticides analysis, mycotoxins analysis, heavy metals analysis, residual solvents analysis, microbial analysis, foreign matter inspection, moisture content analysis, water activity analysis, vitamin E acetate, homogeneity testing, and hemp analysis, as well as consulting services in the areas of analytical testing, cannabis testing regulations, test methods, laboratory information management systems, and product quality and safety. The company was formerly known as Cannabis Clonal Corporation and changed its name to Steep Hill Inc. in February 2022. Steep Hill Inc. was founded in 2008 and is based in Toronto, Canada.
- Sector
- Financial
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Sameet Kanade
- Employees
- 6
- Website
- www.steephill.com
- Address
- 120 Adelaide Street West, Toronto, ON, M5H 1T1, CA
Steep Hill Inc (GPIN) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 1 | 6 | 15 |
| Technical Analysis | 1 | 6 | 3 |
| Moving Averages | 0 | 0 | 12 |



